FDA issues software guidance

Article

The FDA has released the first draft of a guideline for good manufacturingpractices for computerized medical devices. The guideline willapply to the manufacturers of all computerized medical products,including computed tomography and magnetic resonance

The FDA has released the first draft of a guideline for good manufacturingpractices for computerized medical devices. The guideline willapply to the manufacturers of all computerized medical products,including computed tomography and magnetic resonance imaging.

The agency will determine whether to finalize the guidelineafter a period of industry comments. If the FDA decides to proceed,it will modify the guidance on the basis of those comments, saidW. Fred Hooten, director of the FDA division of compliance programs,office of compliance and surveillance.

The guideline is called the "Application of the medicaldevice GMPs to computerized devices and manufacturing processes--medicaldevice GMP guidance for FDA investigators." Its purpose isto assist agency field operatives in their inspections of manufacturingfacilities.

In addition to covering products, the draft guideline coverssoftware and hardware intended to control automated device manufacturingprocesses, including quality assurance and record keeping. Theguidance does not contain instructions on how to validate software.

"We would like to see the industry associations--HIMAand NEMA--develop some software validation guidance rather thanour doing it," Hooten said. "They are the ones who aremost knowledgeable in that area."

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.